It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Cervical cancer, despite being preventable through primary and secondary prevention strategies, remains one of the leading causes of morbidity and mortality among women in Brazil. This study aimed to analyze the temporal, spatial, and space-time patterns of cervical cancer mortality in Brazil. An ecological study was conducted using temporal, spatial, and space-time analysis techniques, using death certificates with cervical cancer as the underlying cause or associated condition among females in Brazil from 2000 to 2021. Death certificate and population data were provided by the Department of Health Informatics of the Unified Health System (DATASUS) and the Brazilian Institute of Geography and Statistics (IBGE), respectively. A total of 123,306 deaths associated with cervical cancer among women were registered during the study period. A rising trend in mortality was detected since 2014 onwards, after 14 years of decline. Particularly, an increase in mortality was observed among the younger age groups, and in the North and Northeast regions regardless of age. Heterogeneity in the spatial distribution of cervical cancer mortality was observed, with high mortality clusters around the country, but mostly concentrated in the North and Northeast regions. These findings suggest a need and an opportunity to develop efficient and effective health policies targeting those regions and groups of women at higher risk which in turn will allow for fast and significant reductions in cervical cancer mortality in Brazil.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 University of Brasília, Department of Tropical Medicine, Brasília, Brazil (GRID:grid.7632.0) (ISNI:0000 0001 2238 5157); Ministry of Health, Department of Communicable Diseases, Brasília, Brazil (GRID:grid.414596.b) (ISNI:0000 0004 0602 9808); Oswaldo Cruz Foundation, Center for Epidemiology and Health Surveillance, Brasília, Brazil (GRID:grid.418068.3) (ISNI:0000 0001 0723 0931)
2 University of Brasília, Department of Tropical Medicine, Brasília, Brazil (GRID:grid.7632.0) (ISNI:0000 0001 2238 5157)
3 Federal University of Sergipe, Department of Nursing, Lagarto, Brazil (GRID:grid.411252.1) (ISNI:0000 0001 2285 6801)
4 Ministry of Health, Department of Communicable Diseases, Brasília, Brazil (GRID:grid.414596.b) (ISNI:0000 0004 0602 9808)
5 University of Tiradentes, Department of Medicine, Aracaju, Brazil (GRID:grid.442005.7) (ISNI:0000 0004 0616 7223)
6 Brazilian National Cancer Institute (INCA), Cancer Early Detection Division, Rio de Janeiro, Brazil (GRID:grid.419166.d)
7 Brazilian National Cancer Institute (INCA), Division of Clinical Research and Technological Development Research and Innovation Coordination, Rio de Janeiro, Brazil (GRID:grid.419166.d); Teaching and Research Coordination, National Institute of Cardiology (INC), Professional Master’s Program in Health Technology Assessment, Rio de Janeiro, Brazil (GRID:grid.419171.b) (ISNI:0000 0004 0481 7106)
8 National Cancer Institute, National Institutes of Health, Division of Cancer Epidemiology and Genetics, Rockville, USA (GRID:grid.48336.3a) (ISNI:0000 0004 1936 8075)
9 Oswaldo Cruz Foundation, Center for Epidemiology and Health Surveillance, Brasília, Brazil (GRID:grid.418068.3) (ISNI:0000 0001 0723 0931); University Hospital of Brasília, Brazilian Hospital Services Company, Brasília, Brazil (GRID:grid.411215.2)
10 University of Brasília, Department of Tropical Medicine, Brasília, Brazil (GRID:grid.7632.0) (ISNI:0000 0001 2238 5157); Oswaldo Cruz Foundation, Center for Epidemiology and Health Surveillance, Brasília, Brazil (GRID:grid.418068.3) (ISNI:0000 0001 0723 0931); University Hospital of Brasília, Brazilian Hospital Services Company, Brasília, Brazil (GRID:grid.411215.2)